Market Tracker

07/29 1:56pm ET

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.42
Delayed Data
As of 1:36pm ET
 +0.08 / +5.97%
Today’s Change
0.78
Today|||52-Week Range
1.88
+43.57%
Year-to-Date
No recent news for Enzon Pharmaceuticals Inc.

Today’s Trading

Previous close1.34
Today’s open1.35
Day’s range1.35 - 1.48
Volume1,168,095
Average volume (3 months)1,600,322
Market cap$59.6M
Dividend yield--
Data as of 1:36pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+82.79%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-9.63%
P/E ratio2.3
Price/Sales1.55
Price/Book2.01

Competitors

 Today’s
change
Today’s
% change
PARNParnell Pharmaceutic...+0.04+0.89%
VICLVical Inc-0.01-1.58%
APDNApplied DNA Sciences...+0.02+0.88%
PRANPrana Biotechnology ...+0.01+0.86%
Data as of 1:38pm ET, 07/29/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.2M
Annual profit (last year)$28.8M
Net profit margin92.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts